Novelix Pharmaceuticals Convenes 32nd AGM and Proposes Key Board Appointments
Novelix Pharmaceuticals Ltd · Annual General Meeting · 08 Sept 2026, 3:49 am
Novelix Pharmaceuticals Convenes 32nd AGM and Proposes Key Board Appointments Novelix Pharmaceuticals has scheduled its 32nd AGM for 30th Sep'26 via video conferencing. Key agenda items include adopting standalone audited financial statements for FY25–26 and approving the re-appointment of Non-Executive Director Ms. Sridevi Belide, who retires by rotation. Additionally, the company seeks shareholder approval via special resolution to appoint Mr. Gnana Prakash Gattu as Whole-Time Director for a five-year term from 29th Aug'26 to 28th Aug'31. The remote e-voting cut-off date is set for 23rd Sep'26, with voting running from 27th Sep'26 to 29th Sep'26.
Original exchange filing (PDF)
More announcements from Novelix Pharmaceuticals Ltd
- Submission of Intimation of Corporate office opening. · 18 Nov 2026
- Submission of Supply agreement intimation. · 13 Nov 2026
- Submission of intimation of change in Designation of Director. · 12 Nov 2026
- Attached as per above Subject. · 12 Nov 2026
- Submission of unaudited financial results for the quarter and half year ended September, 2026. · 12 Nov 2026
- Submission of outcome of the Board Meeting. · 12 Nov 2026
- Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve unaudited standalone .... · 11 Nov 2026
- Attached · 03 Oct 2026
